Join
Live feed
·
NEWSReleasevia Quantisnow
DMK Pharmaceuticals Corporation logo

DMK Pharmaceuticals Regains Full Rights From U.S. WorldMeds For SYMJEPI And Provides Corporate Update

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track DMK (DMK Pharmaceuticals Corporation) and more on Quantisnow.